drugset / Trial / NCT02332616

Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty

NCT02332616 ↗

RandomizedParallel-groupQuadruple-blind

Summary

This study evaluates the pathophysiological effects of a single dose of methylprednisolone administered prior to total knee-arthroplasty surgery. The investigators examine the effect on complement activation. Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will receive placebo. The investigators hypothesize that the group receiving methylprednisolone will experience beneficial inhibition of the undesirable parts of the complement activation.

Timeline

Start
2015-01
Primary completion
2016-04
Completion
2016-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 125 mg Intravenous

Indications